13F HOLDINGS REPORT
Saturn V Capital Management LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001964437-24-000004
Total Value
$249.4M
Positions
21
Other Managers
0
Confidential Omitted
No
Holdings (21)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CRINETICS PHARMACEUTICALS IN | CRNX | 660,143 | $30.9M | 12.39% |
| 2 | ARGENX SE | ARGX | 65,597 | $25.8M | 10.35% |
| 3 | CYTOKINETICS INC | CYTK | 263,701 | $18.5M | 7.41% |
| 4 | KALVISTA PHARMACEUTICALS INC | KALV | 1,441,952 | $17.1M | 6.86% |
| 5 | MERUS N V | N5749R100 | 376,629 | $17.0M | 6.80% |
| 6 | DISC MEDICINE INC | IRON | 254,803 | $15.9M | 6.36% |
| 7 | ASCENDIS PHARMA A/S | ASND | 103,428 | $15.6M | 6.27% |
| 8 | ANAPTYSBIO INC | ANABV | 586,031 | $13.2M | 5.29% |
| 9 | VAXCYTE INC | PCVX | 185,175 | $12.6M | 5.07% |
| 10 | COGENT BIOSCIENCES INC | COGT | 1,595,021 | $10.7M | 4.30% |
| 11 | AMICUS THERAPEUTICS INC | FOLD | 898,381 | $10.6M | 4.24% |
| 12 | BIOMARIN PHARMACEUTICAL INC | BMRN | 119,188 | $10.4M | 4.17% |
| 13 | SYNDAX PHARMACEUTICALS INC | SNDX | 397,997 | $9.5M | 3.80% |
| 14 | ABIVAX SA | AAVXF | 622,970 | $8.9M | 3.57% |
| 15 | IRONWOOD PHARMACEUTICALS INC | IRWD | 944,912 | $8.2M | 3.30% |
| 16 | PHATHOM PHARMACEUTICALS INC | PHAT | 500,987 | $5.3M | 2.13% |
| 17 | ITEOS THERAPEUTICS INC | 46565G104 | 387,095 | $5.3M | 2.12% |
| 18 | APELLIS PHARMACEUTICALS INC | APLS | 71,463 | $4.2M | 1.68% |
| 19 | GERON CORP | GERN | 1,123,995 | $3.7M | 1.49% |
| 20 | MORPHIC HLDG INC | 61775R105 | 85,632 | $3.0M | 1.21% |
| 21 | CABALETTA BIO INC | CABA | 173,173 | $3.0M | 1.18% |